CTMC

About CTMC

CTMC is a company focused on accelerating cell therapy innovation from research to clinical application. They offer fully integrated 360o Solutions with a patient-adjacent manufacturing model in collaboration with The University of Texas MD Anderson Cancer Center. Their mission is to simplify the path from bench to bedside, reducing risk, timelines, and costs while delivering transformative therapies to patients.

Products & Services

360o Solutions:A comprehensive model to accelerate cell therapy from research to clinical reality, integrating manufacturing capabilities (viral vector production to CAR-T, NK, and TIL therapies), seamless solutions from development to commercialization, and bundled expertise in development, regulatory, clinical, and operational support.

BioExpertise:Decades of specialized cell therapy experience with a collaborative team of scientists and technicians, and expertise as trailblazers in TIL therapy through innovative platforms and proprietary methods.

BioInnovation:Driving financial value through collaboration and global access, sharing expertise via the Network Alliance, providing access to advanced technologies and proprietary reagents, and expanding global reach to democratize cell therapy.

Network Alliance:A platform offering long-term value through services, materials, and products to advance cell therapy development, including specialized training, educational programs, and readiness assessments for local manufacturing.

Partnerships + Collaborations:Support for early-stage biotechs and academic teams with expertise and infrastructure, plus strategic collaborations with technology and materials innovators for efficient, de-risked development and manufacturing solutions.

Specialties

Cell Therapy Manufacturing TIL Therapy CAR-T Therapy NK Therapy Viral Vector Production Clinical Trial Support Regulatory and Operational Expertise

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 9100000 MR: - FA: 9.1M FAN: 9100000	D: 2023-05-18 FD: 2023-05-18	1 investors

Grant Latest

2023-05-18

$9.1M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jason Bock

Co-Founder + CEO

LinkedIn (Pro only)

H

Houman Mesghali

Co-Founder + COO

LinkedIn (Pro only)

A

Amy Hay

Chief Business Officer

LinkedIn (Pro only)

D

Duane Avant

Chief Technical Officer

P

Priya Balasubramanian

Head of Quality Control + Analytical Development

C

Chantale Bernatchez

Head of Process Development

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

CTMC Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

About CTMC

Products & Services

Specialties

Funding History

Growth Metrics

Team & Leadership

Recent News

CTMC Announces New Product Launch

Leadership Team Expands with Industry Veteran

Company Recognized as Industry Leader

Key Competitors

Competitor Alpha

Competitor Beta

Competitor Gamma

Competitor Delta

Company Details

Similar Companies

Technology Stack